Novoheart Holdings Inc (CVE:NVH) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23, with a volume of 83258 shares trading hands. The stock had previously closed at C$0.25.
The business’s 50-day moving average price is C$0.26. The firm has a market cap of $46.14 million and a price-to-earnings ratio of -2.67.
Novoheart Company Profile (CVE:NVH)
Novoheart Holdings Inc operates as a stem cell biotechnology company in the United States, Canada, and Hong Kong. It offers an array of next-generation human heart tissue prototypes. The company provides a range of bioengineering technologies known as the MyHeart platform, including the human mini-heart ‘novoHeart' that is capable of pumping and ejecting fluid.
Featured Story: Beta
Receive News & Ratings for Novoheart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novoheart and related companies with MarketBeat.com's FREE daily email newsletter.